Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature

Infection. 2020 Dec;48(6):871-877. doi: 10.1007/s15010-020-01483-8. Epub 2020 Jul 28.

Abstract

Introduction: The novel coronavirus SARS-CoV-2 has spread all over the world causing a global pandemic and representing a great medical challenge. Nowadays, there is limited knowledge on the rate of co-infections with other respiratory pathogens, with viral co-infection being the most representative agents. Co-infection with Mycoplasma pneumoniae has been described both in adults and pediatrics whereas only two cases of Chlamydia pneumoniae have been reported in a large US study so far.

Methods: In the present report, we describe a series of seven patients where co-infection with C. pneumoniae (n = 5) or M. pneumoniae (n = 2) and SARS-CoV-2 was detected in a large teaching hospital in Rome.

Results and conclusion: An extensive review of the updated literature regarding the co-infection between SARS-CoV-2 and these atypical pathogens is also performed.

Keywords: COVID-19; Chlamydia pneumoniae; Co-infection; Mycoplasma pneumoniae; SARS-CoV-2 infection.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • COVID-19 / diagnosis*
  • COVID-19 / epidemiology
  • COVID-19 / therapy
  • COVID-19 / virology*
  • Chlamydial Pneumonia / diagnosis*
  • Chlamydial Pneumonia / epidemiology
  • Chlamydial Pneumonia / microbiology*
  • Chlamydial Pneumonia / therapy
  • Coinfection*
  • Comorbidity
  • Disease Management
  • Female
  • Hospitals, Teaching
  • Humans
  • Male
  • Middle Aged
  • Pneumonia, Mycoplasma / diagnosis*
  • Pneumonia, Mycoplasma / epidemiology
  • Pneumonia, Mycoplasma / microbiology*
  • Pneumonia, Mycoplasma / therapy
  • Retrospective Studies
  • Rome / epidemiology
  • Symptom Assessment
  • Treatment Outcome
  • Young Adult